• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023

tetano

Editor, Senior Moderator
Vaccine


. 2024 Feb 14:S0264-410X(24)00167-1.
doi: 10.1016/j.vaccine.2024.02.020. Online ahead of print. U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023

Christopher Duggar[SUP] 1 [/SUP], Jeanne M Santoli[SUP] 2 [/SUP], Cameron Noblit[SUP] 1 [/SUP], Lori B Moore[SUP] 1 [/SUP], Roua El Kalach[SUP] 1 [/SUP], Carolyn B Bridges[SUP] 3 [/SUP]



Affiliations
Abstract

During December 2020 through May 2023, the Centers for Disease Control and Prevention's (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.

Keywords: COVID-19 pandemic; COVID-19 vaccine; Emergency preparedness; Lessons learned; Vaccine distribution.

 
Back
Top Bottom